603439.SS
GuiZhou SanLi Pharmaceutical Co., Ltd. [603439.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
603439.SS Stock Summary
Top 603439.SS Correlated Resources
603439.SS
Top 10 Correlated ETFs
603439.SS
Top 10 Correlated Stocks
603439.SS
In the News
603439.SS Financial details
Company Rating
-
Market Cap
6.1B
Income
255.61M
Revenue
1.46B
Book val./share
-
Cash/share
-
Dividend
0.1
Dividend %
0.54%
Employees
1.56K
Optionable
No
Shortable
Yes
Earnings
30 Aug 2023
P/E
29.67
Forward P/E
-
PEG
4.22
P/S
5.2
P/B
5.56
P/C
-
P/FCF
227.2
Quick Ratio
2
Current Ratio
2.27
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.63
EPS next Y
-
EPS next Q
-
EPS this Y
32.43%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
10.31%
Revenue last 5Y
10.71%
Revenue Q/Q
20.29%
EPS Q/Q
27.27%
-
-
-
-
SMA20
-7.16%
SMA50
-6.37%
SMA100
-12.74%
Inst Own
-
Inst Trans
-
ROA
13%
ROE
20%
ROC
0.2%
Gross Margin
73%
Oper. Margin
20%
Profit Margin
17%
Payout
20%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
11.92-20.65
52W High
-40.8%
52W Low
+7.64%
RSI
36.67
Rel Volume
0.42
Avg Volume
6.86M
Volume
2.88M
Perf Week
-6.4%
Perf Month
-10.03%
Perf Quarter
-13.77%
Perf Half Y
-16.8%
-
-
-
-
Beta
0.756
-
-
Volatility
0.33%, 0.51%
Prev Close
-0.34%
Price
11.84
Change
-0.42%
603439.SS Financial Performance
603439.SS Frequently Asked Questions
What is GuiZhou SanLi Pharmaceutical Co., Ltd. stock symbol ?
GuiZhou SanLi Pharmaceutical Co., Ltd. is a CN stock and trading under the symbol 603439.SS
What is GuiZhou SanLi Pharmaceutical Co., Ltd. stock quote today ?
GuiZhou SanLi Pharmaceutical Co., Ltd. stock price is $11.84 today.
Is GuiZhou SanLi Pharmaceutical Co., Ltd. stock public?
Yes, GuiZhou SanLi Pharmaceutical Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 6.86M
- Market Capitalization 6.1B
- Employee 1.56K
- CEO Mr. Hai Zhang
- Headquarters Guiyang,CN
- IPO Date 2020-04-28
-
Website
https://www.gz-sanli.com 
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular and cerebrovascular drugs, digestive medicine, trauma injury medication, rehabilitation medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Guiyang, China.
